Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | STAT3 | P40763 | 1/20 | 0.61 |
| ▸ | EPHX2 | P34913 | 3/20 | 0.38 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.34 |
| ▸ | POLB | P06746 | 2/20 | 0.34 |
| ▸ | GAA | P10253 | 2/20 | 0.34 |
| ▸ | APEX1 | P27695 | 2/20 | 0.34 |
| ▸ | HSP90AA1 | P07900 | 2/20 | 0.34 |
| ▸ | MAPT | P10636 | 1/20 | 0.34 |
| ▸ | RECQL | P46063 | 1/20 | 0.34 |
| ▸ | SLC28A3 | Q9HAS3 | 3/20 | 0.33 |
| ▸ | XDH | P47989 | 1/20 | 0.32 |
| ▸ | P4HB | P07237 | 2/20 | 0.32 |
| ▸ | ACHE | P22303 | 1/20 | 0.32 |
| ▸ | CA12 | O43570 | 1/20 | 0.32 |
| ▸ | CA2 | P00918 | 1/20 | 0.32 |
| ▸ | AKR1B1 | P15121 | 1/20 | 0.32 |
| ▸ | CA4 | P22748 | 1/20 | 0.32 |
| ▸ | CA7 | P43166 | 1/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22662483 | 1.00 | STAT3 (0.61) | STAT3EPHX2KDM4EPOLBGAA | |
| SCHEMBL22662484 | 1.00 | STAT3 (0.61) | STAT3EPHX2KDM4EPOLBGAA | |
| SCHEMBL29655170 | 0.95 | STAT3 (0.61) | STAT3EPHX2KDM4EPOLBGAA | |
| SCHEMBL10307294 | 0.91 | STAT3 (0.49) | STAT3EPHX2KDM4EPOLBGAA | |
| SCHEMBL10307500 | 0.84 | STAT3 (0.39) | STAT3EPHX2KDM4EPOLBGAA | |
| SCHEMBL29655256 | 0.83 | STAT3 (0.39) | STAT3EPHX2KDM4EPOLBGAA | |
| SCHEMBL22645247 | 0.83 | STAT3 (0.59) | STAT3KDM4EAPEX1MAPTRECQL | |
| SCHEMBL13998188 | 0.81 | STAT3 (0.43) | STAT3 | |
| SCHEMBL29425739 | 0.79 | STAT3 (0.69) | STAT3GAAHSP90AA1SLC28A3CA12 | |
| SCHEMBL29655347 | 0.78 | STAT3 (0.67) | STAT3KDM4EHSP90AA1XDHCA12 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1858 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4363043-B1 | COMPOSITIONS FOR USE IN METHODS FOR INCREASING CANCER CELL SENSITIVITY TO ALTERNATING ELECTRIC FIELDS | NOVOCURE GMBH (CH) | 2026-04-22 | — | — | EP | claimed |
| US-12594421-B2 | Compositions and methods for increasing cancer cell sensitivity to alternating electric fields | NOVOCURE GMBH (CH) | 2026-04-07 | — | — | US | claimed |
| EP-4561377-B1 | AEROSOL-GENERATING ARTICLE WITH EMBEDDED AVERSIVE AGENT | PHILIP MORRIS PRODUCTS SA (CH) | 2026-03-25 | — | — | EP | claimed |
| EP-4561379-B1 | AEROSOL-GENERATING ARTICLE WITH AN ISOLATED AVERSIVE COMPONENT | PHILIP MORRIS PRODUCTS SA (CH) | 2026-03-25 | — | — | EP | claimed |
| EP-4561378-B1 | AEROSOL-GENERATING ARTICLE WITH AVERSIVE AGENT | PHILIP MORRIS PRODUCTS SA (CH) | 2026-03-25 | — | — | EP | claimed |
| EP-4694699-A2 | COMPOSITIONS AND METHODS OF CONTROLLING MAMMALIAN SATIETY | VitaKey Inc. (US) | 2026-02-18 | — | — | EP | claimed |
| US-20260041141-A1 | AEROSOL-GENERATING ARTICLE WITH AN ISOLATED AVERSIVE COMPONENT | PHILIP MORRIS PRODUCTS SA (CH) | 2026-02-12 | — | — | US | claimed |
| US-20250339680-A1 | COMPOSITIONS AND METHODS FOR INCREASING CANCER CELL SENSITIVITY TO ALTERNATING ELECTRIC FIELDS | NOVOCURE GMBH (CH) | 2025-11-06 | — | — | US | claimed |
| US-20250331550-A1 | AEROSOL-GENERATING ARTICLE EMBEDDED AVERSIVE AGENT | PHILIP MORRIS PRODUCTS SA (CH) | 2025-10-30 | — | — | US | claimed |
| US-20250331549-A1 | AEROSOL-GENERATING ARTICLE WITH AVERSIVE AGENT | PHILIP MORRIS PRODUCTS SA (CH) | 2025-10-30 | — | — | US | claimed |
| WO-2008119527-A2 | AGONISTS OF BITTER TASTE RECEPTORS AND USES THEREOF | DEUTSCHES INSTITUT FÜR ERNÄHRUNGSFORSCHUNG POSTDAM-REHBRÜCKE STIFTUNG DES ÖFFENTLICHEN RECHTS (DE) | 2008-10-09 | — | — | WO | claimed |
| WO-2008119526-A1 | AGONISTS OF BITTER TASTE RECEPTORS AND USES THEREOF | DEUTSCHES INSTITUT FÜR ERNÄHRUNGSFORSCHUNG POTSDAM-REHBRÜCKE STIFTUNG DES ÖFFENTLICHEN RECHTS (DE) | 2008-10-09 | — | — | WO | claimed |
| CN-101273738-A | Method for preparing recombined sour milk drinks having higher viable bacteria counts at normal temperature | BEIJING FUMENGTE BIOTECHNOLOGY (CN) | 2008-10-01 | — | — | CN | claimed |
| CN-101273736-A | Method for preparing fermented milk having higher viable counts at normal temperature | BEIJING FUMENGTE BIOTECHNOLOGY (CN) | 2008-10-01 | — | — | CN | claimed |
| CN-100422737-C | Preparation method of 'Xue Fu Zhu Yu' capsule and quality standard thereof | TIANJIN HONGRENTANG PHARMACEUT (CN) | 2008-10-01 | — | — | CN | claimed |
| EP-1972203-A1 | Use of 4-hydroxychalkon derivatives for masking an unpleasant taste | Symrise GmbH & Co. KG (DE) | 2008-09-24 | — | — | EP | claimed |
| US-20080227867-A1 | USE OF 4-HYDROXYCHALCONE DERIVATIVES FOR MASKING AN UPLEASANT TASTE | SYMRISE GMBH & CO. KG (DE) | 2008-09-18 | — | — | US | claimed |
| CN-1996008-A | Identification method for Chinese globe flower and amygdalin in Chinese globe flower antipyretic capsule | NINGXIA QIYUAN PHARMACEUTICAL (CN) | 2007-07-11 | — | — | CN | claimed |
| CN-1730027-A | Method for preparing anti-hepatitis active part from swertia main pharmaceutical plant | QINGHAI PULANTE PHARMACEUTICAL (CN) | 2006-02-08 | — | — | CN | claimed |
| CN-1634520-A | Preparation process of Tibet capilary artemisia | BEIJING PULANTE PHARMACEUTICAL (CN) | 2005-07-06 | — | — | CN | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080227867-A1 | USE OF 4-HYDROXYCHALCONE DERIVATIVES FOR MASKING AN UPLEASANT TASTE | TAS2R45, TAS2R43, TAS2R30 | STAT3 4885/4885EPHX2 626/4885KDM4E 1299/4885 |
| US-12594421-B2 | Compositions and methods for increasing cancer cell sensitivity to alternating electric fields | PTK2, GSK3B, MTOR | STAT3 103/4885EPHX2 3779/4885KDM4E 2098/4885 |
| US-20260041141-A1 | AEROSOL-GENERATING ARTICLE WITH AN ISOLATED AVERSIVE COMPONENT | ATXN10, ATXN2, TAS2R60 | STAT3 2639/4885EPHX2 2102/4885KDM4E 4327/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.